Invesco’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-149,982
| Closed | -$133K | – | 4055 |
|
2022
Q4 | $133K | Buy |
149,982
+27,971
| +23% | +$24.8K | ﹤0.01% | 3756 |
|
2022
Q3 | $192K | Buy |
122,011
+3,519
| +3% | +$5.54K | ﹤0.01% | 3670 |
|
2022
Q2 | $238K | Sell |
118,492
-4,701
| -4% | -$9.44K | ﹤0.01% | 3633 |
|
2022
Q1 | $287K | Sell |
123,193
-4,810
| -4% | -$11.2K | ﹤0.01% | 3618 |
|
2021
Q4 | $596K | Buy |
128,003
+7,660
| +6% | +$35.7K | ﹤0.01% | 3284 |
|
2021
Q3 | $919K | Buy |
120,343
+23,142
| +24% | +$177K | ﹤0.01% | 3114 |
|
2021
Q2 | $942K | Buy |
97,201
+34,463
| +55% | +$334K | ﹤0.01% | 3117 |
|
2021
Q1 | $519K | Sell |
62,738
-42,570
| -40% | -$352K | ﹤0.01% | 3306 |
|
2020
Q4 | $719K | Sell |
105,308
-89,206
| -46% | -$609K | ﹤0.01% | 3055 |
|
2020
Q3 | $2.17M | Sell |
194,514
-1,555,220
| -89% | -$17.3M | ﹤0.01% | 2445 |
|
2020
Q2 | $11M | Buy |
1,749,734
+1,667,976
| +2,040% | +$10.5M | ﹤0.01% | 1589 |
|
2020
Q1 | $150K | Sell |
81,758
-11,905
| -13% | -$21.8K | ﹤0.01% | 3442 |
|
2019
Q4 | $317K | Sell |
93,663
-6,199
| -6% | -$21K | ﹤0.01% | 3357 |
|
2019
Q3 | $214K | Sell |
99,862
-3,953
| -4% | -$8.47K | ﹤0.01% | 3486 |
|
2019
Q2 | $277K | Sell |
103,815
-3,573
| -3% | -$9.53K | ﹤0.01% | 3480 |
|
2019
Q1 | $510K | Buy |
+107,388
| New | +$510K | ﹤0.01% | 3286 |
|
2018
Q4 | – | Sell |
-1,368,184
| Closed | -$6.02M | – | 3830 |
|
2018
Q3 | $6.02M | Buy |
+1,368,184
| New | +$6.02M | ﹤0.01% | 2036 |
|
2015
Q3 | – | Sell |
-329
| Closed | -$6K | – | 4032 |
|
2015
Q2 | $6K | Buy |
+329
| New | +$6K | ﹤0.01% | 4144 |
|